Sun Pharma Q4 net soars 225%

CORPORATE SCORECARD

Net profit for the year ended 2007-08 stood at Rs 1486.9 crore, 89.6 per cent higher than the Rs 784.2 crore posted in the corresponding previous year. Net sales for the year also grew to Rs 3356.5 crore, 57.14 per cent higher than the Rs 2135.9 crore posted in the corresponding previous year.

"We've achieved higher than expected sales and profit, built one of the strongest product pipelines, and begun to take calculated risks. This quarter, we've begun to see value creation from our intellectual property and NDDS capability. Our US performance complements strong numbers across all our business segments," said Dilip Shanghvi, Chairman and Managing Director.

Sun's US performance was mainly powered by the launch of two products, generics versions of Protonix and Ethyol, which were launched